These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 17666113)
1. Surfactant for acute respiratory failure in children: where should it fit in our treatment algorithm? Schindler M Crit Care; 2007; 11(4):148. PubMed ID: 17666113 [TBL] [Abstract][Full Text] [Related]
2. Surfactant therapy for acute respiratory failure in children: a systematic review and meta-analysis. Duffett M; Choong K; Ng V; Randolph A; Cook DJ Crit Care; 2007; 11(3):R66. PubMed ID: 17573963 [TBL] [Abstract][Full Text] [Related]
3. Beneficial effect of exogenous surfactant in infants suffering acute respiratory distress syndrome after cardiac surgery. Cai J; Su Z; Zhou Y; Shi Z; Xu Z; Liu J; Xu Z; Yang Y Eur J Cardiothorac Surg; 2011 Sep; 40(3):557-62. PubMed ID: 21371901 [TBL] [Abstract][Full Text] [Related]
9. Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. Spragg RG; Lewis JF; Walmrath HD; Johannigman J; Bellingan G; Laterre PF; Witte MC; Richards GA; Rippin G; Rathgeb F; Häfner D; Taut FJ; Seeger W N Engl J Med; 2004 Aug; 351(9):884-92. PubMed ID: 15329426 [TBL] [Abstract][Full Text] [Related]
10. Role of surfactant in the pathophysiology of the acute respiratory distress syndrome (ARDS). Hartog A; Gommers D; Lachmann B Monaldi Arch Chest Dis; 1995 Oct; 50(5):372-7. PubMed ID: 8541821 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic approach to a child with acute respiratory distress syndrome: a report of two cases. Nosal S; Durdik P; Luptakova A; Sutovska M; Nosal V; Jesenak M; Havlicekova Z; Hamzik J; Banovcin P J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():43-51. PubMed ID: 19218632 [TBL] [Abstract][Full Text] [Related]
12. Surfactant rescue or liquid ventilation for adult respiratory distress syndrome. D'Ancona G; Ricci M; Karamanoukian H J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):760-2. PubMed ID: 11139126 [No Abstract] [Full Text] [Related]
13. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Gregory TJ; Steinberg KP; Spragg R; Gadek JE; Hyers TM; Longmore WJ; Moxley MA; Cai GZ; Hite RD; Smith RM; Hudson LD; Crim C; Newton P; Mitchell BR; Gold AJ Am J Respir Crit Care Med; 1997 Apr; 155(4):1309-15. PubMed ID: 9105072 [TBL] [Abstract][Full Text] [Related]
14. Acute respiratory distress syndrome in the pediatric age: an update on advanced treatment. Marraro GA; Chen C; Piga MA; Qian Y; Spada C; Genovese U Zhongguo Dang Dai Er Ke Za Zhi; 2014 May; 16(5):437-47. PubMed ID: 24856990 [TBL] [Abstract][Full Text] [Related]
15. A pilot, randomized, controlled clinical trial of lucinactant, a peptide-containing synthetic surfactant, in infants with acute hypoxemic respiratory failure. Thomas NJ; Guardia CG; Moya FR; Cheifetz IM; Markovitz B; Cruces P; Barton P; Segal R; Simmons P; Randolph AG; Pediatr Crit Care Med; 2012 Nov; 13(6):646-53. PubMed ID: 22791092 [TBL] [Abstract][Full Text] [Related]
16. Surfactant replacement therapy in ARDS: white knight or noise in the system? Nicholas TE; Doyle IR; Bersten AD Thorax; 1997 Feb; 52(2):195-7. PubMed ID: 9059486 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of exogenous surfactant therapy in pediatric patients with acute hypoxemic respiratory failure. Thomas NJ; Hollenbeak CS; Lucking SE; Willson DF Pediatr Crit Care Med; 2005 Mar; 6(2):160-5. PubMed ID: 15730602 [TBL] [Abstract][Full Text] [Related]
18. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial. Willson DF; Thomas NJ; Markovitz BP; Bauman LA; DiCarlo JV; Pon S; Jacobs BR; Jefferson LS; Conaway MR; Egan EA; JAMA; 2005 Jan; 293(4):470-6. PubMed ID: 15671432 [TBL] [Abstract][Full Text] [Related]
19. The role of exogenous surfactant in the treatment of acute lung injury. Lewis JF; Veldhuizen R Annu Rev Physiol; 2003; 65():613-42. PubMed ID: 12517997 [TBL] [Abstract][Full Text] [Related]